Balyasny Asset Management
OMED

Balyasny Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Balyasny Asset Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-175,895
Closed -$3.97M – 1522
2015
Q4 		$3.97M Buy
+175,895
New +$3.97M 0.03% 467